Product Description
Other than introducing a foreign agent into the patients bod, the AV graft, access type is comparable to AV fistula in many ways. Companies are currently working on new technologies for AV graft which could solve many of the issues associated with currently available AV grafts. Devices in development are polyurethane grafts that incorporate a biomimetic scaffold into the structure, which can allow for endothelial cell ingrowth.
AV grafts continue to be commonly used in the United States, despite the alternative options. AV grafts have the advantage of maturing in just two weeks, thus acting as a viable option for obese patients lacking adequate fistulae as well as for those patients whose native fistulae fail to mature. The material of choice for AV grafts is polytetrafluoroethylene (ePTFE), which is also used in small diameter surgical grafts.
Segments Covered in This Market
- AV Access Graft Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the many companies in the U.S. AV Graft Market, W.L. Gore was the leader, followed by C. R. Bard and LeMaitre Vascular Inc. W.L. Gore achieved their leading position by marketing products such as the GORE® INTERING®, GORE® PROPATEN®, GORE® ACUSEAL and the GORE® Hybrid vascular grafts. The GORE® INTERING® has an all-ePTFE (polytetrafluoroethylene) unibody construction and is the lowest profile, radially-supported graft on the market. Other companies analyzed include Terumo, Atrium Maquet Group, Artegraft, and Merit Medical Systems.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled U.S. Market Report Suite for Dialysis Devices and Concentrates – MedSuite
